Literature DB >> 2498520

Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.

L B Gilleland1, H E Gilleland, J A Gibson, F R Champlin.   

Abstract

Aminoglycoside-resistant variants of Pseudomonas aeruginosa strain PAO1 were readily selected by culturing the organism in medium containing increasing concentrations of gentamicin, tobramycin or amikacin until the strains were growing in a concentration of drug 128-fold greater than the minimal inhibitory concentration for the sensitive parent strain. These resistant strains exhibited characteristics previously associated with the impermeability type of resistance mechanism, i.e., they grew more slowly than the parent strain, the resistance was unstable in the absence of the antibiotic, and adaptation to one of the antibiotics conferred cross-resistance to other aminoglycosides. The adapted strains grew, with minimal morphological alterations, in concentrations of the various aminoglycosides that normally produced cell envelope damage, misshapen and filamentous cell formation, and cell lysis in the sensitive strain. Neither protein H1 nor phospholipid alterations appear to play a significant role in adaptive resistance to aminoglycoside antibiotics in this model system. The acquisition of adaptive resistance to the aminoglycoside antibiotics did not confer resistance to polymyxin B, another cationic antibiotic which is thought to share binding sites within the outer membrane with the aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498520     DOI: 10.1099/00222615-29-1-41

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  22 in total

Review 1.  Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

Authors:  P A Lambert
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.

Authors:  P D Lister; A Pong; S A Chartrand; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 4.  Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action.

Authors:  T P Tim Cushnie; Noëlle H O'Driscoll; Andrew J Lamb
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

5.  Once daily dosing of aminoglycosides in pediatric cystic fibrosis patients: a review of the literature.

Authors:  Sarah K Wassil; Kristie M Fox; James W White
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

6.  Novel Aminoglycoside-Tolerant Phoenix Colony Variants of Pseudomonas aeruginosa.

Authors:  Devin Sindeldecker; Kelly Moore; Anthony Li; Daniel J Wozniak; Matthew Anderson; Devendra H Dusane; Paul Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 7.  Aminoglycosides: the complex problem of antibiotic mechanisms and clinical applications.

Authors:  T Montie; P Patamasucon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 8.  Aminoglycoside adaptive resistance: importance for effective dosage regimens.

Authors:  M L Barclay; E J Begg
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 9.  Programmed death in bacteria.

Authors:  K Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

10.  Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients.

Authors:  Donna M Kraus; Manjunath P Pai; Keith A Rodvold
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.